Department of Health and Social Care

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

As a Government department, we work collaboratively with the devolved administrations to drive forward our objective of supporting people to lead more independent, healthier lives for longer.

While health is primarily devolved and each health system operates in its own context, there are strong benefits from sharing experiences and learning between the devolved administrations. While ministers have not recently discussed pressures on accident and emergency services in recent months, Department and NHS England officials periodically speak informally with counterparts on urgent and emergency care issues.

The Department has not undertaken an analysis of the information collected as part of the 2025 medical specialty training programme to assess the location of applicants at the point of application.

The health and wellbeing of our National Health Service staff, including midwives, is a top priority.

The independent National Maternity and Neonatal Investigation, chaired by Baroness Amos, is expected to publish findings in the Spring. My Rt Hon. Friend, the Secretary of State for Health and Social Care, will chair the National Maternity and Neonatal Taskforce to address the recommendations and develop a new national action plan to drive improvements across maternity and neonatal care.

As set out in the 10-Year Health Plan, we will work with the Social Partnership Forum to introduce a new set of staff standards for modern employment.

It is for local NHS trusts to determine what working patterns may be required to meet local service needs in the interest of patients, considering the provisions set out in the Working Time Regulations 1998.

There is no obligation on National Health Service providers to advertise positions for British nationals before foreign nationals, or to hire British residents before overseas residents for nursing and midwife positions.

At the same time, the 10 Year Workforce Plan will ensure the NHS has the right people in the right places, with the right skills to care for patients when they need it.

As part of that plan, we will outline strategies for improving retention, productivity, training, and reducing attrition, enhancing conditions for all staff while gradually reducing reliance on international recruitment, without diminishing the value of their contributions.

As of July 2025, East of England Ambulance Service NHS Trust (EEAST) had an average annual sickness absence rate of 7.6%. This has remained at the same rate as the average for the 12 months to July 2024. The EEAST average annual sickness absence rate is 0.9 percentage points higher than the average annual sickness absence rate for all ambulance trusts in England, which is 6.7%. This difference has been consistent across the past five years.

NHS England publishes monthly information on the sickness absence rates of staff in National Health Service bodies, which is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhs-sickness-absence-rates

The primary cause for sickness absence amongst professionally qualified ambulance staff remains, anxiety, depression and mental health conditions.

The EEAST recognises that its sickness levels remain high and is committed to reducing these while ensuring its staff are properly supported.

The EEAST continues to work with system partners on effective measures to ensure its staff can handover patients safely as soon as possible and has taken actions to address its sickness levels. These include training for line managers on how to best support staff, a wide-ranging health and wellbeing offer, and temporary and permanent redeployment.

Local employers across the NHS have in place arrangements for supporting staff including occupational health provision, employee support programmes and a focus on healthy working environments.

As set out in the 10-Year Health Plan, we will roll out staff treatment hubs to ensure all staff have access to high quality occupational health support, including for mental health and musculoskeletal conditions, the two main causes of sickness absence in the NHS.

To further support this ambition, we are working with the Social Partnership Forum to introduce a new set of staff standards for modern employment, covering issues such as access to healthy meals, support to work healthily and flexibly, and tackling violence, racism and sexual harassment in the workplace.

The Government is committed to prioritising women’s health, including endometriosis care. The Department, through the National Institute for Health and Care Research, has commissioned studies focused on endometriosis diagnosis, treatment, and patient experience.

Diagnosis may involve magnetic resonance imaging (MRI) or ultrasound, but laparoscopy remains the definitive diagnostic and treatment method. We are taking action to transform diagnostic services and increase capacity, including MRI and ultrasound. This includes expanding existing community diagnostic centres (CDCs) and building up to five new ones in 2025/26. Our Elective Reform Plan also committed to CDCs opening 12 hours per day, seven days a week, delivering more same-day tests and consultations.

Surgical hubs are helping endometriosis patients get quicker treatment. National Health Service surgical hubs deliver high-volume, low-complexity elective surgeries, including gynaecological procedures. Currently, over half of the 123 operational elective surgical hubs in England provide gynaecology services, and laparoscopies are a key part of this offering. The Elective Reform Plan commits to expand the number of hubs over the next three years to increase surgical capacity and reduce waiting times.

From 2027, a new “online hospital” will also offer patients the choice to access specialist care, including for menstrual problems potentially indicating endometriosis or fibroids from home, providing additional appointments to cut waiting times.

The following table shows the trend in stroke admissions for the last five years:

Source: Fingertips, avaiable at the following link:
https://fingertips.phe.org.uk/search/stroke%20admissions#page/4/gid/1/pat/159/par/K02000001/ati/15/are/E92000001/iid/90986/age/1/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

Decisions about recruitment are a matter for individual National Health Service employers, who manage this at a local level to ensure they have the staff they need to deliver effective care.

The Government is committed to publishing a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed service set out in the 10-Year Health Plan. The 10 Year Workforce Plan will ensure the NHS has the right people in the right places, with the right skills when needed.

Decisions about recruitment are a matter for individual National Health Service employers, who manage this at a local level to ensure they have the staff they need to deliver effective care.

The Government is committed to publishing a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed service set out in the 10-Year Health Plan.

The 10 Year Workforce Plan will ensure the NHS has the right people in the right places, with the right skills when needed.

We are engaging with partners throughout this process. As we continue the open and wide-ranging conversations we’ve been having with staff, patients, and organisations, including royal colleges across the country, we will ensure that the engagement is robust and representative of different stakeholder groups.

The Government is committed to achieving a 25% reduction in premature mortality due to cardiovascular disease (CVD) and stroke across England. To accelerate progress and tackle variation across the country, a new CVD Modern Service Framework will be published in 2026. This framework will support improvement, reduce inequalities, and foster innovation where it is needed most.

No assessment has been made of adopting elements of the structured clinical programme established in Poland in the 1980s for heart transplant surgery. The National Health Service’s heart transplant programme provides life-saving heart transplants for adults, those 16 years old or older, with end-stage heart failure, involving assessment, surgery, and lifelong care.

NHS England has been undertaking a review of heart and lung transplantation services, building on a report commissioned by the Department, named Honouring the gift of organ donation, published in 2023 and avaiable at the following link:

https://www.gov.uk/government/publications/honouring-the-gift-of-donation-utilising-organs-for-transplant

The goals of the review are to increase the number of transplants, improve patient outcomes, reduce inequalities in access to transplants, and improve patient experience.

Published guidance on ventilation in healthcare settings includes the Health Technical Memorandum 03-01: Specialised ventilation for healthcare premises. It gives comprehensive advice and guidance on the legal requirements, design implications, maintenance, and operation of specialised ventilation in healthcare premises providing acute care. Further information is avaiable at the following link:

https://www.england.nhs.uk/publication/specialised-ventilation-for-healthcare-buildings/

NHS England will update Health Technical Memorandums, including HTM 03-01, when necessary.

In December 2025, an average of 2,888 hospital beds were occupied by patients with flu across all acute settings, including both General and Acute and Critical Care beds.

These figures are published in the NHS England Winter Situation Reports, which are available at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/uec-sitrep/urgent-and-emergency-care-daily-situation-reports-2025-26/

It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancers, as early and quickly as possible, and to treat it faster, to improve outcomes.

To tackle the late diagnoses of blood cancers, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. We will get the NHS diagnosing blood cancers earlier and treating them faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.

The National Cancer Plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention, and research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next 10 years. This will benefit all cancer patients, including leukaemia and myeloma patients.

It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancers, as early and quickly as possible, and to treat it faster, to improve outcomes.

To tackle the late diagnoses of blood cancers, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. We will get the NHS diagnosing blood cancers earlier and treating them faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.

The National Cancer Plan will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention, and research and innovation. It will seek to improve every aspect of cancer care to better the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next 10 years. This will benefit all cancer patients, including leukaemia and myeloma patients.

The NHS England Neurology Transformation Programme and the Getting It Right First Time (GIRFT) initiative are playing an important role in improving care for people with Tourette’s syndrome, including in Yeovil. These programmes aim to ensure that patients receive timely, high-quality, and evidence-based care. For Tourette’s, this means supporting local integrated care boards (ICBs) to develop clearer referral pathways, improve access to multidisciplinary teams, and embed best practice in local services. GIRFT also uses data to identify gaps in provision and highlight where improvements can be made, helping to ensure that people with Tourette’s are not left behind in the transformation of neurological care.

Our 10-Year Health Plan is designed to transform the way we deliver care for people with long-term conditions, including Tourette’s syndrome. By shifting the focus from hospital-based treatment to more integrated, community-led care, the plan aims to ensure that individuals with Tourette’s can access timely support closer to home, including in Yeovil.

The NHS England Neurology Transformation Programme and the Getting It Right First Time (GIRFT) initiative are playing an important role in improving care for people with Tourette’s syndrome, including in Yeovil. These programmes aim to ensure that patients receive timely, high-quality, and evidence-based care. For Tourette’s, this means supporting local integrated care boards (ICBs) to develop clearer referral pathways, improve access to multidisciplinary teams, and embed best practice in local services. GIRFT also uses data to identify gaps in provision and highlight where improvements can be made, helping to ensure that people with Tourette’s are not left behind in the transformation of neurological care.

Our 10-Year Health Plan is designed to transform the way we deliver care for people with long-term conditions, including Tourette’s syndrome. By shifting the focus from hospital-based treatment to more integrated, community-led care, the plan aims to ensure that individuals with Tourette’s can access timely support closer to home, including in Yeovil.

No national assessment he has made of whether disabled parking provision at National Health Service and primary care premises is adequate to meet patient demand.

Disabled parking provision on the public sector estate is mandated through national planning rules, and all NHS facilities must meet the requirements.

NHS organisations decide how they provide parking locally, based on the needs of patients, visitors, and staff, as well as environmental factors. The NHS car parking guidance requires free parking to be provided for four groups: disabled people; frequent outpatient attenders; parents of sick children staying overnight; and staff working night shifts. Further information is avaiable at the following link:

https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as how we will reduce waiting times for diagnosis and treatment.

Improving access to all treatment services, including radiotherapy, remains a key priority for the Government. Our commitment to radiotherapy services is demonstrated by our £70 million investment in new LINAC radiotherapy machines to replace older, less efficient equipment. This crucial investment will boost treatment efficiency and productivity, freeing up capacity and reduce waiting times for patients. These new machines are currently being rolled out and have already started treating cancer patients across the country.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as how we will reduce waiting times for diagnosis and treatment.

Improving access to all treatment services, including radiotherapy, remains a key priority for the Government. Our commitment to radiotherapy services is demonstrated by our £70 million investment in new LINAC radiotherapy machines to replace older, less efficient equipment. This crucial investment will boost treatment efficiency and productivity, freeing up capacity and reduce waiting times for patients. These new machines are currently being rolled out and have already started treating cancer patients across the country.

The latest estimates for smoking-attributable mortality in England are for the period 2017 to 2019. The Smoking Profile, produced by the Department, reports 191,903 smoking-attributable deaths of people aged 35 years old and over in the period 2017 to 2019 in England, which is just under 64,000 deaths each year. Further information on the Smoking Profile is available at the following link:

https://fingertips.phe.org.uk/profile/tobacco-control/data#page/1/gid/1938132887/pat/159/par/K02000001/ati/15/are/E92000001/yrr/1/cid/4/tbm/1

It is important that the National Health Service is as accessible as possible to those that need it most. That is why the NHS already provides free hospital car parking to those in greatest need. This includes disabled blue badge holders, frequent outpatient attenders, parents of children staying overnight and NHS staff working overnight.

More widely, all NHS trusts are expected to follow the published NHS Car Parking Guidance. This states that car parking charges, where they exist, should be reasonable for the area, with further information available at the following link:

https://www.gov.uk/government/publications/nhs-patient-visitor-and-staff-car-parking-principles/nhs-patient-visitor-and-staff-car-parking-principles

NHS England has published guidance through Health Technical Memorandum 05:03 – Firecode, which provides guidance on operational provisions for fire safety for health sector buildings and premises. This guidance is avaiable at the following link:

https://www.england.nhs.uk/publication/fire-safety-in-the-nhs-health-technical-memorandum-05-03/

This HTM is updated when necessary. For example, the ‘Training’ section of the guidance was last updated in 2024.

Newborn babies whose hearing screening suggests they may have deafness and hearing impairment are referred for an audiological assessment within four weeks.

A family centred approach underpins all recall processes to prioritise clear communication and support for families, ensuring transparency and minimizing harm. Working with the National Deaf Children’s Society, a range of communications have been developed with families to help support families of babies and children who are deaf or have hearing loss.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, commissioned the recently published, independent Kingdon review that includes a number of recommendations on how children’s hearing services need to be improved.

The supply and distribution of flu vaccines for the majority of NHS England’s flu programme is managed by individual providers. NHS England and the UK Health Security Agency (UKHSA) work with the pharmaceutical sector to support adequate supply, understand provider ordering, and signpost providers to the continued availability of stock towards the end of the season.

There is currently good availability of flu vaccines in Bedfordshire, Luton, and Milton Keynes. Local practices and pharmacies have not reported any significant disruption to supply or distribution. NHS England regional teams monitor availability of appointments and stock levels, and are working with community pharmacies, general practices, and other providers to identify and escalate any providers that need further support with supply, which the NHS England Regional Vaccination Operations Cell will assist with.

For the children’s flu programme, the UKHSA centrally procures and manages the supply of all vaccines to ensure that eligible children aged under 18 years old who present for vaccination can be offered an appropriate vaccine. Supply remains available throughout the entire flu season. Flu vaccines for children are made available to order via the UKHSA’s online ordering platform ImmForm. General practices are able to place weekly orders and receive weekly deliveries of children’s flu vaccines from the UKHSA. School immunisation teams are able to place orders and receive deliveries up to twice per week.

The Department does not hold data on cancer incidence for the United Kingdom. The latest data on bladder cancer incidence available, in England, can be found at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2023

It is the responsibility of the NHS West Yorkshire Integrated Care Board (ICB) to meet the needs of patients diagnosed with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, in the Leeds Central and Headingly constituency, supported by national improvement programmes such as Getting It Right First Time (GIRFT) and NHS RightCare. These programmes provide evidence-based tools and guidance to reduce unwarranted variation and improve patient outcomes.

In November 2025, GIRFT published a new handbook, Optimising care for patients with Inflammatory Bowel Disease, in addition to an updated IBD pathway. This handbook provides practical advice, key actions, and examples of innovative practices to improve the care of National Health Service patients with Crohn's disease and ulcerative colitis.

Gastroenterology is a top priority for reform in the Elective Reform Plan. Specific action in gastroenterology includes developing an integrated pathway across primary, community, and secondary care for common gastroenterology conditions. We will also drive rapid adoption of remote monitoring in appropriate gastroenterology pathways.

We are also introducing an ‘online hospital’ through NHS Online. This will give people on certain pathways the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times. IBD is amongst nine initial conditions for online referrals from 2027.

It is the responsibility of the NHS West Yorkshire Integrated Care Board (ICB) to meet the needs of patients diagnosed with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, in the Leeds Central and Headingly constituency, supported by national improvement programmes such as Getting It Right First Time (GIRFT) and NHS RightCare. These programmes provide evidence-based tools and guidance to reduce unwarranted variation and improve patient outcomes.

In November 2025, GIRFT published a new handbook, Optimising care for patients with Inflammatory Bowel Disease, in addition to an updated IBD pathway. This handbook provides practical advice, key actions, and examples of innovative practices to improve the care of National Health Service patients with Crohn's disease and ulcerative colitis.

Gastroenterology is a top priority for reform in the Elective Reform Plan. Specific action in gastroenterology includes developing an integrated pathway across primary, community, and secondary care for common gastroenterology conditions. We will also drive rapid adoption of remote monitoring in appropriate gastroenterology pathways.

We are also introducing an ‘online hospital’ through NHS Online. This will give people on certain pathways the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times. IBD is amongst nine initial conditions for online referrals from 2027.

Reducing the number of lives lost to cancer, including penile cancer, is a key aim of the National Cancer Plan. The plan will be published early this year. It will include further details on how we will improve outcomes for patients with cancer, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates. This will benefit all cancer patients, including penile cancer patients.

The Government supports Scott Arthur’s Private Members Bill on rare cancers which will make it easier for clinical trials into rare cancers, including penile cancer patients, to take place in England by ensuring the patient population can be easily contacted by researchers. This will ensure that the National Health Service will remain at the forefront of medical innovation and is able to provide patients with the newest, most effective treatment options, and ultimately boost survival rates.

NHS England will publish a Breast Screening Programme Uptake Improvement Review this year, to help improve uptake and address inequalities.

The review supports breast screening service providers with national solutions such as:

• introducing digital options for sending out invitations and managing appointments;
• raising awareness of the importance of screening through the media; and
• facilitating learning and gathering evidence to inform programme policy, pathway changes, and guidance.

For England, the UK Health Security Agency (UKHSA) publishes provisional vaccine uptake data throughout the flu season. Weekly national level data for general practice (GP) patients is available from October to January, at the following link:

https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2025-to-2026-season

Monthly national and regional level data for GP patients, school-aged children, and frontline healthcare workers (HCWs) is available from October to January. The latest monthly data for the 2025 to 2026 season includes all vaccinations given between 1 September to 30 November 2025, and is avaiable at the following link:

https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures

Up to 4 January 2026, over 18 million people eligible for the national programme had been vaccinated so far this season.

As set out in the plan for reforming elective care, the Government is committed to improving performance on cancer waiting times.

To improve access to cancer treatment, the Government is investing an extra £26 billion in the National Health Service and providing it with the resources it needs, including community diagnostic centres, to ensure patients are diagnosed faster and earlier so that they receive timely access to treatment. £70 million will also be spent on replacing out-of-date radiotherapy equipment so that cancer patients benefit from faster and safer cancer treatment using the most up-to-date technology. Replacing these older machines will save as many as 13,000 appointments from being lost to equipment breakdown.

NHS England has partnered with the charity Hope For Tomorrow to establish mobile chemotherapy units across England, bringing chemotherapy and cancer treatments closer to patients' homes, reducing waiting time for hospital appointments, with units staffed by specialist nurses offering personalised care.

The NHS has made important progress on the treatment of cancer, including breast cancer, delivering an extra 40,000 operations, scans, and appointments each week to ensure faster treatment for those who need it most.

The Government is guided by the UK National Screening Committee (UK NSC), an independent scientific advisory committee which makes its recommendations based on internationally recognised criteria and a rigorous evidence review and consultation process. It is only where the committee is confident that screening would provide more good than harm that a screening programme is recommended, as all medical interventions carry an inherent risk.

The NHS Breast Screening Programme (NHS BSP) offers all women in England between the ages of 50 to 71 years old the opportunity to be screened every three years for breast cancer, to help detect abnormalities and intervene early to reduce the number of lives lost to invasive breast cancer.

The AgeX research trial has been looking at the effectiveness of offering some women one extra screen between the ages of 47 to 49 years old, and one between the ages of 71 to 73 years old. The biggest trial of its kind ever to be undertaken, AgeX will provide robust evidence about the effectiveness of screening in these age groups, including the benefit and harms. The UK NSC will review the publication of the age extension trial when it reports.

Women with a very high risk of breast cancer, for example due to family history, may be offered screening earlier and more frequently, sometimes using magnetic resonance imaging rather than a mammogram.

While the NHS BSP does not automatically invite women for breast screening after their 71st birthday, women aged 71 years old or over can still have breast screening every three years if they want to, by calling their local breast screening service to ask for an appointment.

The Department recognises the importance of supporting and maintaining children’s right to play in healthcare settings.

The NHS England and Starlight Play Well Toolkit, published in June 2025, includes the first national guidelines and standards for commissioning and delivering health play services in England. It aims to improve access to child-friendly care and specialised health play services across paediatric healthcare.

NHS England is promoting the toolkit to managers of health play services across a wide range of settings, including community clinics, emergency departments, children’s hospices, and acute paediatric wards. The toolkit provides clear guidance on supporting practical training and mentorship in healthcare settings.

The Play Well toolkit aims to ensure that health play services have the right staff with the right qualifications to deliver a high-quality service. This includes ensuring that services are able to support the training and development of the health play specialists they employ.

Health play specialists are trained through foundation degrees and prospective health play specialists can also be trained through the apprenticeship route.

Global Burden of Disease data considers the top ten public health factors in the United Kingdom in 2023 in order of importance to be: tobacco, high body mass index, dietary risks, high fasting plasma glucose, high blood pressure, high alcohol use, high cholesterol, occupational risks, kidney dysfunction, and drug use. Further information on the Global Burden of Disease data is available at the following link:

https://vizhub.healthdata.org/gbd-compare/

The following table shows the various estimates of the cost to the National Health Service of the five factors specified:

Comparisons of costs should not be made between these estimates because of the different methodologies used in their construction.

We will deliver a Neighbourhood Health Service that serves everybody, everywhere across the country, including children and young people.

An important feature of our new Neighbourhood Health Service will be the rollout of Neighbourhood Health Centres in every community, including multidisciplinary neighbourhood teams who will work together around the needs of children and families.

The make-up of neighbourhood multi-disciplinary teams for children and young people is locally determined by integrated care boards. Local commissioners determine the role for each practitioner within neighbourhood multidisciplinary teams based upon the clinical interventions being undertaken.

Play specialists could be involved as part of a neighbourhood multi-disciplinary teams for children and young people but this is likely only appropriate for multi-disciplinary teams who provide face to face patient care. For example, when a general practitioner and paediatrician hold a joint clinic in the practice or local setting.

The Department is committed to improving timely diagnosis and management of arthritis and other musculoskeletal (MSK) conditions across England.

The National Institute for Health and Care Excellence (NICE) has published guidance to support health and care professionals in the early diagnosis and management of rheumatoid arthritis and osteoarthritis. These guidelines help ensure that patients receive evidence-based care as early as possible.

NHS England is working to improve early diagnosis rates through its Getting It Right First Time (GIRFT) rheumatology programme. This initiative focuses on reducing variation in care, improving referral pathways, and ensuring patients with suspected arthritis and other MSK conditions are assessed promptly by specialists.

The Government has funded NHS England’s GIRFT programme to deploy its proven Further Faster model for MSK community services. The programme has been designed to reduce waiting times for community MSK appointments and to enhance access to quality treatment, working with integrated care board leaders to improve data and metrics and referral pathways to wider support services.

We are working together to further develop the approach to better enable integrated care systems to commission the delivery of high quality MSK services in the community, which will benefit patients now and into the future.

The Department is committed to improving timely diagnosis and management of arthritis and other musculoskeletal (MSK) conditions across England.

The National Institute for Health and Care Excellence (NICE) has published guidance to support health and care professionals in the early diagnosis and management of rheumatoid arthritis and osteoarthritis. These guidelines help ensure that patients receive evidence-based care as early as possible.

NHS England is working to improve early diagnosis rates through its Getting It Right First Time (GIRFT) rheumatology programme. This initiative focuses on reducing variation in care, improving referral pathways, and ensuring patients with suspected arthritis and other MSK conditions are assessed promptly by specialists.

The Government has funded NHS England’s GIRFT programme to deploy its proven Further Faster model for MSK community services. The programme has been designed to reduce waiting times for community MSK appointments and to enhance access to quality treatment, working with integrated care board leaders to improve data and metrics and referral pathways to wider support services.

We are working together to further develop the approach to better enable integrated care systems to commission the delivery of high quality MSK services in the community, which will benefit patients now and into the future.

The Green Book is written for healthcare professionals. The chapter on human papillomavirus (HPV) does highlight the causal link between infection with this virus, cervical cancer, and some non-cervical cancer including those of the head and neck. The HPV chapter 18a from the Green Book is available at the following link:

https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a

Broader UK Health Security Agency guidance on HPV also highlights the protection the vaccine provides against HPV infection and related conditions. This public‑facing information also explains that the vaccine helps protect against cancers of the mouth and is available at the following link:

https://assets.publishing.service.gov.uk/media/64919b26103ca6000c03a212/HPV_Vaccination_For_All_-_English_Leaflet_from_September_2023.pdf

It also highlights that the greatest risk comes from infection with high-risk types of HPV. There is very good evidence that the vaccine in use in the United Kingdom offers excellent protection against these high-risk types.

The Department recognises the importance of supporting and maintaining children’s right to play in healthcare settings.

The NHS England and Starlight Play Well Toolkit, published in June 2025, includes the first national guidelines and standards for commissioning and delivering health play services in England. It aims to improve access to child-friendly care and specialised health play services across paediatric healthcare.

To support adoption of Play Well standards, NHS England is promoting the toolkit to managers of health play services across a wide range of settings, including community clinics, emergency departments, children’s hospices, and acute paediatric wards. The toolkit provides clear guidance on supporting practical training and mentorship in healthcare settings.

A range of communication channels have been used to raise awareness, including engagement with services via professional bodies, messaging via the Chief Nursing Officer, a blog posts and ongoing promotion of the toolkit across the National Health Service through operational delivery networks, directly to trusts and directly with professional groups.

In conducting health needs assessments to inform their commissioning decisions, integrated care boards (ICBs) will have access to a wide range of data sources, including public health data, hospital statistics, primary care data, and social care metrics.

NHS England is working with the UK Fatal Anaphylaxis Register (UKFAR) to develop a mechanism for sharing relevant patient safety anaphylaxis incidents, including the reporting of anaphylaxis in hospitals. The aim will be for the UKFAR to extract and share patient safety incidents reported to the national databases, the National Reporting and Learning System and Learn from Patient Safety Events, relating to severe allergic reactions. Work has been progressing on this.

The National Allergy Strategy Group, an external group of stakeholders, is developing a UK National Allergy Strategy 2025-2035. The Department will carefully consider and respond to it when we receive it next year.

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.

The JCVI has advised that population immunity to COVID-19 has increased due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.

The JCVI has also advised that as currently available COVID-19 vaccines provide limited protection against transmission and mild or asymptomatic disease, the focus of the programme is on offering vaccination to those most likely to directly benefit from vaccination. These are the oldest adults and individuals who are immunosuppressed.

The Government has accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:

• adults aged 75 years old and over;
• residents in care homes for older adults; and
• individuals aged six months and over who are immunosuppressed.

As for all vaccines, the JCVI keeps the evidence under regular review.

We have now exceeded our pledge to deliver an extra two million appointments across elective, diagnostic, and cancer care, having now delivered over five million more appointments as the first step to ensuring earlier and faster access to treatment.

Between November 2024 to October 2025, approximately 110,000 more patients were diagnosed or had cancer ruled out within 28 days compared to the previous 12 months. This supports the achievement of the 62-day treatment standard, as faster diagnosis means that patients can begin treatment sooner.

The latest available data shows that the 62-day treatment standard for the NHS Buckinghamshire, Oxfordshire and Berkshire West Integrated Care Board has improved by 3.5% between October 2024 and October 2025.

However, we recognise that there is more to do, including for patients in Newbury.

To ensure that the most advanced treatment is available to the patients who need it, and so that patients can be treated sooner, the Government has also invested £70 million of central funding to replace outdated radiotherapy machines, including one at the Royal Berkshire Hospital.